$21.20
1.286.43%
Last update: Nov 6, 3:04 PM
Faeth Therapeutics Inc (FTH) Stock Price, Quote, News & History
FTHNASDAQ
You can purchase shares of Faeth Therapeutics (NASDAQ:FTH) through any online brokerage.
Other companies in Faeth Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Faeth Therapeutics has a consensus price target of $58.91.
The stock price for Faeth Therapeutics (NASDAQ: FTH) is $21.2 last updated November 6, 2026 at 3:04 PM EST.
There are no upcoming dividends for Faeth Therapeutics.
Faeth Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Faeth Therapeutics.
Faeth Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral...
